Late Stage Cancer
Nivolumab/Chemo Yields Long-Term Survival in Advanced Gastric Cancers
https://www.cancernetwork.com/view/nivolumab-chemo-yields-long-term-survival-in-advanced-gastric-cancers…
CheckMate 649: 5-Year Results of First-Line Nivolumab Plus Chemotherapy in Advanced Gastric, GEJ, and Esophageal Adenocarcinoma
https://oncodaily.com/new-paper-alert/checkmate-649-5-year-survival…
Nivolumab Exhibits Enhanced DFS Outcomes in Resected Gastric Cancers
https://www.cancernetwork.com/view/nivolumab-exhibits-enhanced-dfs-outcomes-in-resected-gastric-cancers…
Updated Nivolumab Data Solidify Use in Advanced Gastric/GEJ/Esophageal Cancers
https://www.cancernetwork.com/view/updated-nivolumab-data-solidify-use-in-advanced-gastric-gej-esophageal-cancers…
Zolbetuximab Plus Chemotherapy Offers Survival Benefits in Treatment-Naive HER2– Gastric/GEJ Cancer
https://www.onclive.com/view/zolbetuximab-plus-chemotherapy-offers-survival-benefits-in-treatment-naive-her2-gastric-gej-cancer…
Evaluation of pembrolizumab plus cisplatin and fluorouracil in radical treatment for patients with T4b esophageal squamous cell carcinoma
https://bmcgastroenterol.biomedcentral.com/articles/10.1186/s12876-024-03382-w…
Nivolumab Plus Neoadjuvant Chemoradiation Fails to Enhance pCR Rate in Esophageal/GEJ Adenocarcinoma
https://www.onclive.com/view/nivolumab-plus-neoadjuvant-chemoradiation-fails-to-enhance-pcr-rate-in-esophageal-gej-adenocarcinoma…
ESOPEC Trial: FLOT Protocol Proves Superior to CROSS Regimen in Locally Advanced Esophageal Cancer
https://ascopost.com/issues/july-25-2024/esopec-trial-flot-protocol-proves-superior-to-cross-regimen-in-locally-advanced-esophageal-cancer/…
The Drug Tevimbra Now Approved For Use in Esophageal Cancer– Finally Some Help For Patients In Great Need
https://www.survivornet.com/articles/the-fda-approves-tevimbra-for-use-in-esophageal-cancer/…